In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin.

BO-1341, a new antipseudomonal semisynthetic cephalosporin, was evaluated for in vitro and in vivo antibacterial activities in comparison with ceftazidime, cefotaxime, and cefoperazone. The in vitro activity of BO-1341 was generally superior or comparable to the activities of the reference antibioti...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Nakagawa, S, Sanada, M, Matsuda, K, Hashizume, T, Asahi, Y, Ushijima, R, Ohtake, N, Tanaka, N
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1989
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172677/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2510590/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.33.9.1423
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!